These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
163 related items for PubMed ID: 9488076
1. Excision of residual masses of metastatic germ cell tumours after chemotherapy: the role of extraperitoneal surgical approaches. Christmas TJ, Doherty AP, Rustin GJ, Seckl MJ, Newlands ES. Br J Urol; 1998 Feb; 81(2):301-8. PubMed ID: 9488076 [Abstract] [Full Text] [Related]
2. Resection of postchemotherapy residual masses and limited retroperitoneal lymphadenectomy in patients with metastatic testicular nonseminomatous germ cell tumors. Aprikian AG, Herr HW, Bajorin DF, Bosl GJ. Cancer; 1994 Aug 15; 74(4):1329-34. PubMed ID: 8055456 [Abstract] [Full Text] [Related]
3. Comparison of histological results from the resection of residual masses at different sites after chemotherapy for metastatic non-seminomatous germ cell tumours. Hartmann JT, Candelaria M, Kuczyk MA, Schmoll HJ, Bokemeyer C. Eur J Cancer; 1997 May 15; 33(6):843-7. PubMed ID: 9291803 [Abstract] [Full Text] [Related]
4. Delayed orchiectomy after chemotherapy in patients with advanced testicular cancer. Ondrus D, Hornák M, Breza J, Mat'oska J, Schnorrer M, Belan V, Kausitz J. Int Urol Nephrol; 2001 May 15; 32(4):665-7. PubMed ID: 11989561 [Abstract] [Full Text] [Related]
5. Does necrosis on frozen-section analysis of a mass after chemotherapy justify a limited retroperitoneal resection in patients with advanced testis cancer? Herr HW. Br J Urol; 1997 Oct 15; 80(4):653-7. PubMed ID: 9352708 [Abstract] [Full Text] [Related]
6. Metastatic nonseminomatous germ cell tumors of the testis: results of elective and salvage surgery for patients with residual retroperitoneal masses. Hendry WF, Norman AR, Dearnaley DP, Fisher C, Nicholls J, Huddart RA, Horwich A. Cancer; 2002 Mar 15; 94(6):1668-76. PubMed ID: 11920527 [Abstract] [Full Text] [Related]
7. [Postchemotherapy residual tumour resection in complex metastatic sites of advanced testicular germ cell tumours]. Paffenholz P, Pfister D, Heidenreich A. Urologe A; 2016 May 15; 55(5):632-40. PubMed ID: 26820659 [Abstract] [Full Text] [Related]
8. Thoracotomy for postchemotherapy resection of pulmonary residual tumor mass in patients with nonseminomatous testicular germ cell tumors: aggressive surgical resection is justified. Gels ME, Hoekstra HJ, Sleijfer DT, Nijboer AP, Molenaar WM, Ebels T, Schraffordt Koops H. Chest; 1997 Oct 15; 112(4):967-73. PubMed ID: 9377960 [Abstract] [Full Text] [Related]
10. Simultaneous retroperitoneal, thoracic, and cervical resection of postchemotherapy residual masses in patients with metastatic nonseminomatous germ cell tumors of the testis. Brenner PC, Herr HW, Morse MJ, Sheinfeld J, Aprikian A, Bosl GJ, Motzer RJ, Bajorin DF, Schantz S, Fair WR, Burt M. J Clin Oncol; 1996 Jun 15; 14(6):1765-9. PubMed ID: 8656244 [Abstract] [Full Text] [Related]
11. Resection of small, residual retroperitoneal masses after chemotherapy for nonseminomatous testicular cancer: a decision analysis. Steyerberg EW, Marshall PB, Keizer HJ, Habbema JD. Cancer; 1999 Mar 15; 85(6):1331-41. PubMed ID: 10189139 [Abstract] [Full Text] [Related]
12. [Urologic treatment of testicular germ cell cancer]. Fernández Gómez JM, Escaf Barmadah S, Guate Ortiz JL, Martín Huescar A, Fresno Forcelledo F, García Rodríguez J, Rodríguez Faba O, Jalón Monzón A, Rodríguez Martínez JJ. Arch Esp Urol; 2002 Oct 15; 55(8):927-36. PubMed ID: 12455283 [Abstract] [Full Text] [Related]
13. Retroperitoneal lymphadenectomy for post-chemotherapy residual masses: is a modified dissection and resection of residual masses sufficient? Rabbani F, Goldenberg SL, Gleave ME, Paterson RF, Murray N, Sullivan LD. Br J Urol; 1998 Feb 15; 81(2):295-300. PubMed ID: 9488075 [Abstract] [Full Text] [Related]
14. Resection of residual masses alone: an alternative in surgical therapy of metastatic testicular germ cell tumors after chemotherapy. Ozen H, Ekici S, Sozen S, Ergen A, Tekgül S, Kendi S. Urology; 2001 Feb 15; 57(2):323-7. PubMed ID: 11182346 [Abstract] [Full Text] [Related]
15. Management of post-chemotherapy extra-retroperitoneal residual masses. Carver BS, Sheinfeld J. World J Urol; 2009 Aug 15; 27(4):489-92. PubMed ID: 19373472 [Abstract] [Full Text] [Related]
16. Nonseminomatous germ cell tumors: assessing the need for postchemotherapy contralateral pulmonary resection in patients with ipsilateral complete necrosis. Besse B, Grunenwald D, Fléchon A, Caty A, Chevreau C, Culine S, Théodore C, Fizazi K. J Thorac Cardiovasc Surg; 2009 Feb 15; 137(2):448-52. PubMed ID: 19185168 [Abstract] [Full Text] [Related]
17. Failure of salvage treatment in metastatic testicular teratoma. Whillis D, Coleman RE, Cornbleet MA, Howard GC. Clin Oncol (R Coll Radiol); 1991 May 15; 3(3):141-6. PubMed ID: 1712626 [Abstract] [Full Text] [Related]
18. Risk of residual cancer after complete response following first-line chemotherapy in men with metastatic non-seminomatous germ cell tumour and International Germ Cell Cancer Cooperative Group intermediate/poor prognosis: A multi-institutional retrospective cohort study. Antonelli L, Ardizzone D, Ravi P, Bagrodia A, Mego M, Daneshmand S, Nicolai N, Nazzani S, Giannatempo P, Franza A, Heidenreich A, Paffenholz P, Saoud R, Eggener S, Ho M, Oswald N, Olson K, Tryakin A, Fedyanin M, Naoun N, Javaud C, Fizazi K, King JM, Adra N, Douglawi A, Cary C, Sweeney C, Fankhauser CD. Eur J Cancer; 2023 Mar 15; 182():144-154. PubMed ID: 36787661 [Abstract] [Full Text] [Related]